{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,4,22]],"date-time":"2023-04-22T05:41:12Z","timestamp":1682142072468},"reference-count":27,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2001,11,1]],"date-time":"2001-11-01T00:00:00Z","timestamp":1004572800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2001,11]]},"DOI":"10.1054\/mehy.2001.1427","type":"journal-article","created":{"date-parts":[[2002,9,19]],"date-time":"2002-09-19T14:55:42Z","timestamp":1032447342000},"page":"612-615","source":"Crossref","is-referenced-by-count":1,"title":["Oral vaccination with autologous platelets in chronic autoimmune thrombocytopenic purpura"],"prefix":"10.1054","volume":"57","author":[{"given":"G.","family":"Hermida","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Manj\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Casanova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Rodriguez-Salazar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1054\/mehy.2001.1427_RF1","first-page":"9","article-title":"P\u00farpura trombocitop\u00e9nica idiop\u00e1tica refractaria: tratamiento","volume":"85","author":"Garc\u0131\u0301a","year":"2000","journal-title":"Haematologica"},{"key":"10.1054\/mehy.2001.1427_RF2","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1182\/blood.V88.1.3.3","article-title":"Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology","volume":"88","author":"George","year":"1996","journal-title":"Blood"},{"key":"10.1054\/mehy.2001.1427_RF3","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1111\/j.1365-2141.1995.tb05326.x","article-title":"Pulsed high-dose dexamethasone in refractory chronic idiopathic thrombocytopenia purpura: a report of 10 cases","volume":"91","author":"Caulier","year":"1995","journal-title":"Br J Haematol"},{"key":"10.1054\/mehy.2001.1427_RF4","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1007\/s002620050435","article-title":"Clinical experience with CD-64 directed immunotherapy: an overview","volume":"45","author":"Curnow","year":"1997","journal-title":"Cancer Immunol Immunother"},{"key":"10.1054\/mehy.2001.1427_RF5","first-page":"2014","article-title":"Immune thrombocytopenic purpura, neonatal alloimmune thrombocytopenia, and posttransfusion purpura","author":"Bussel","year":"2000"},{"key":"10.1054\/mehy.2001.1427_RF6","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0037-1963(00)90111-2","article-title":"The pathogenesis of chronic immune (idiopathic) thrombocytopenic purpura","volume":"37","author":"McMillan","year":"2000","journal-title":"Semin Haematol"},{"key":"10.1054\/mehy.2001.1427_RF7","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0950-3536(98)80052-8","article-title":"Immune-mediated thrombocytopenias: basic and immunological aspects","volume":"11","author":"Porcelijn","year":"1998","journal-title":"Balli\u00e8res Clin Hematol"},{"key":"10.1054\/mehy.2001.1427_RF8","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1182\/blood.V83.4.1024.1024","article-title":"Spectrum of Ig classes, specifities, and titers of serum antiglycoproteins in chronic idiopathic thrombocytopenic purpura","volume":"83","author":"He","year":"1994","journal-title":"Blood"},{"key":"10.1054\/mehy.2001.1427_RF9","series-title":"Manual de Transplante Hematopoy\u00e9tico","first-page":"115","year":"1998"},{"key":"10.1054\/mehy.2001.1427_RF10","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/sj.bmt.1701431","article-title":"Failure of autologous stem cell transplantation in refractory thrombocytopenic purpura","volume":"22","author":"Marmont","year":"1998","journal-title":"Bone Marrow Transplant"},{"key":"10.1054\/mehy.2001.1427_RF11","doi-asserted-by":"crossref","first-page":"440","DOI":"10.4049\/jimmunol.140.2.440","article-title":"Suppression of experimental autoimmune encephalomyelitis by the oral administration of myelin basis protein and its fragments","volume":"140","author":"Bitar","year":"1988","journal-title":"J Immunol"},{"key":"10.1054\/mehy.2001.1427_RF12","doi-asserted-by":"crossref","first-page":"7443","DOI":"10.1073\/pnas.83.19.7443","article-title":"Suppression of type II collagen-induced arthritis by intragastric administration of soluble type II collagen","volume":"83","author":"Nagler","year":"1986","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1054\/mehy.2001.1427_RF13","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1002\/1529-0131(199802)41:2<290::AID-ART13>3.0.CO;2-R","article-title":"Treatment of rheumatoid arthritis with oral type II collagen","volume":"41","author":"Barnett","year":"1998","journal-title":"Arthritis Rheum"},{"key":"10.1054\/mehy.2001.1427_RF14","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/PL00000693","article-title":"The role of M cells in mucosal immunity","volume":"57","author":"Hathaway","year":"2000","journal-title":"Cell Mol Life Sci"},{"key":"10.1054\/mehy.2001.1427_RF15","first-page":"785","article-title":"V role of M cells in transepithelial transport of antigens and pathogens to the mucosal immune system","volume":"274","author":"Neutra","year":"1998","journal-title":"Am J Physiol"},{"key":"10.1054\/mehy.2001.1427_RF16","doi-asserted-by":"crossref","first-page":"6688","DOI":"10.1073\/pnas.91.14.6688","article-title":"Induction of anergy or active suppression following oral tolerance is determined by antigen dosage","volume":"91","author":"Fiedman","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1054\/mehy.2001.1427_RF17","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/376177a0","article-title":"Peripheral deletion of antigen-reactive T cells in oral tolerance","volume":"376","author":"Chen","year":"1995","journal-title":"Nature"},{"key":"10.1054\/mehy.2001.1427_RF18","series-title":"Standards for Blood Banks and Transfusion Services, 14th edn.","year":"1991"},{"key":"10.1054\/mehy.2001.1427_RF19","unstructured":"Dzik, W. H. Leukoreduced blood components: laboratory and clinical aspects. In, Rossy, E. C, Simon, T. L, Moss, G. S, Gould, S. A, eds, Principles of Transfusion Medicine, Baltimore, Williams & Wilkins, 1995, 353."},{"key":"10.1054\/mehy.2001.1427_RF20","unstructured":"Lein, H. G, ed, Standards for Blood Banks and Transfusion Services, 17th edn. Bethesda, MD, American Association of Blood Banks, 1996."},{"key":"10.1054\/mehy.2001.1427_RF21","volume":"337","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1054\/mehy.2001.1427_RF22","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1046\/j.1537-2995.2000.40070771.x","article-title":"WBC subsets analysis of WBC-reduced platelet components","volume":"40","author":"Trialzi","year":"2000","journal-title":"Transfusion"},{"key":"10.1054\/mehy.2001.1427_RF23","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0955-3886(00)00028-X","article-title":"Lyophilized platelets: continued development","volume":"22","author":"Bode","year":"2000","journal-title":"Transf Sci"},{"key":"10.1054\/mehy.2001.1427_RF24","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1073\/pnas.92.2.397","article-title":"Presentation of hemostatic and structural properties of rehydrated lyophilized platelets: Potential for long-term storage of dried platelets for transfusion","volume":"92","author":"Read","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1054\/mehy.2001.1427_RF25","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1046\/j.1537-2995.2000.40050527.x","article-title":"Effects of the addition of second-messenger effectors to platelets concentrates for whole-blood donations and stored at 4\u00b0C or \u221280\u00b0C","volume":"40","author":"Lozano","year":"2000","journal-title":"Transfusion"},{"key":"10.1054\/mehy.2001.1427_RF26","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1046\/j.1365-2370.1999.00176.x","article-title":"Human platelet antigens: typing by PCR using sequence-specific primers and their distribution in blood donors resident in Wales","volume":"26","author":"Sellers","year":"1999","journal-title":"Eur J Immunogenet"},{"key":"10.1054\/mehy.2001.1427_RF27","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1046\/j.1365-3148.1997.d01-72.x","article-title":"HPA genotyping by PCR sequence-specific priming (PCR-SSP): a streamlined method for rapid routine investigations","volume":"7","author":"Cavanagh","year":"1997","journal-title":"Transfus Med"}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987701914276?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987701914276?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,22]],"date-time":"2023-04-22T05:23:43Z","timestamp":1682141023000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306987701914276"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,11]]},"references-count":27,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2001,11]]}},"alternative-id":["S0306987701914276"],"URL":"https:\/\/doi.org\/10.1054\/mehy.2001.1427","relation":{},"ISSN":["0306-9877"],"issn-type":[{"value":"0306-9877","type":"print"}],"subject":[],"published":{"date-parts":[[2001,11]]}}}